Gliomatosis Cerebri Program
  • Home
  • Our Team
  • Translational Discovery
  • Patients & Families
  • News & Research
  • Contact

INTERNATIONAL GLIOMATOSIS CEREBRI PLATFORM

Welcome to the International Gliomatosis Cerebri Platform

Our mission is to support world-wide collaboration among physicians, researchers, patients, and families towards finding a cure for gliomatosis cerebri. ​

​What is Gliomatosis Cerebri?

Gliomatosis cerebri (GC) is a pattern of extensive central nervous system disease involvement that may occur in any diffuse infiltrative glioma subtype. Approximately 40 people are diagnosed per year. Outcomes are poor, with a five-year survival rate of only 18.8%. Very little is understood about how, or why, some gliomas spread this way.  ​

​Learn more about gliomatosis cerebri.

Our Objectives

Our program is run by an international network of experts studying and treating GC. We are currently a center of communication for translational scientists, and we intend to become a central resource of clinical and biological information from GC patients from across the world.    

​In the future, we aim to:
  • Facilitate understanding of GC tumorigenesis as it relates to other patterns of disease spread
  • Use our understanding to develop novel therapies, approaches and clinical trials for GC 

Our long-term goal is to establish and maintain a highly collaborative, global research infrastructure, dedicated to pre-clinical and clinical projects related to GC. 
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
 HOME | OUR TEAM  | TRANSLATIONAL DISCOVERY  | PATIENTS & FAMILIES  | NEWS & RESEARCH | CONTACT

©2019 The Gliomatosis Cerebri Platform at Dana-Farber Cancer Institute
  • Home
  • Our Team
  • Translational Discovery
  • Patients & Families
  • News & Research
  • Contact